GYRUS ACMI BICOAG HEMOSTASIS PROBE— 510(k) K123319

Substantially Equivalent

Olympus Surgical Technologies America

FDA 510(k) clearance K123319 for GYRUS ACMI BICOAG HEMOSTASIS PROBE, Substantially Equivalent on 2012-12-14. Applicant: Olympus Surgical Technologies America.

Clearance details

Applicant: Olympus Surgical Technologies America
Product code: Code KNS
Advisory panel: Gastroenterology, Urology
Date received: 2012-10-26
Decision date: 2012-12-14
Decision: Substantially Equivalent
Clearance type: Special
Location: Southborough, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code KNS

product code KNS

Death: 44
Injury: 2,361
Malfunction: 4,771
Total: 7,176

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.